Swedencare AB (publ) Share Price Nasdaq Stockholm
Stocks
SE0008294078
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.52B 367M 315M 297M 271M 506M 34.68B 508M 1.36B 17.76B 1.38B 1.35B 56.56B | P/E 2026 * |
23.4x | P/E 2027 * | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 5.01B 522M 449M 422M 386M 721M 49.38B 723M 1.94B 25.29B 1.96B 1.92B 80.55B | EV / Sales 2026 * |
1.75x | EV / Sales 2027 * | 1.56x |
| Free-Float |
32.62% | Yield 2026 * |
2.02% | Yield 2027 * | 3.17% |
Last Transcript : Swedencare AB (publ)
| 1 day | -4.16% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 31/12/2013 | |
Jenny Graflind
CEO | Chief Executive Officer | 50 | 31/10/2019 |
Annie Bengtsson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 59 | 31/12/2025 | |
| Director/Board Member | 63 | 31/12/2018 | |
Johan Bergdahl
BRD | Director/Board Member | 56 | 31/12/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.16% | -5.47% | - | - | 367M | |
| -0.63% | -1.67% | -50.55% | -59.63% | 31.33B | |
| +0.33% | +2.42% | +32.94% | +109.76% | 12.24B | |
| +0.58% | -0.23% | -11.86% | +5.12% | 3.96B | |
| +0.80% | -1.86% | -2.62% | +19.21% | 3.06B | |
| 0.00% | -2.54% | +50.55% | +33.41% | 2B | |
| +2.27% | -1.00% | +11.92% | +19.90% | 1.88B | |
| -0.86% | +1.35% | -3.04% | +206.49% | 1.55B | |
| +2.77% | +5.09% | -15.95% | +0.55% | 1.23B | |
| +2.03% | +3.07% | -5.38% | -38.73% | 1.07B | |
| Average | +0.29% | -0.24% | +0.67% | +32.90% | 6.48B | |
| Weighted average by Cap. | -0.18% | -0.96% | -19.59% | -1.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.85B 298M 256M 241M 220M 411M 28.14B 412M 1.1B 14.41B 1.12B 1.09B 45.91B | 3.12B 326M 280M 264M 241M 450M 30.81B 451M 1.21B 15.78B 1.22B 1.2B 50.26B |
| Net income | 131M 13.68M 11.76M 11.06M 10.1M 18.89M 1.29B 18.95M 50.7M 662M 51.36M 50.24M 2.11B | 216M 22.54M 19.38M 18.23M 16.64M 31.12M 2.13B 31.23M 83.55M 1.09B 84.64M 82.79M 3.48B |
| Net Debt | 1.49B 155M 134M 126M 115M 215M 14.7B 215M 576M 7.53B 584M 571M 23.98B | 1.37B 142M 122M 115M 105M 197M 13.46B 197M 528M 6.89B 535M 523M 21.96B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
